N-terminal sequences of the human androgen receptor in DNA binding and transrepressing functions

Journal of Steroid Biochemistry and Molecular Biology

Volumn 65, Issue 1-6, 1998, Pages 117-123

  Gast, Andreas ^a   Schneikert, Jean ^a   Cato, Andrew C B ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; CONFERENCE PAPER; HUMAN; LIGAND BINDING; MONKEY; NONHUMAN; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN STABILITY; SEXUAL MATURATION; TRANSACTIVATION;

ANIMALIA;

EID: 0032053196     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(97)00176-3     Document Type: Conference Paper

References (20)

1. Beato M., Herrlich P., Schütz G. Many actors in search of a plot. Cell. 83:1995;851-857.
2. Wurtz J.-M., Bourguet W., Renaud J.-P., Vivat V., Chambon P., Moras D., Gronemeyer H. A canonical structure of the ligand-binding domain of nuclear receptor. Nature Structural Biology. 3:1996;87-94.
3. Zandi E., Galli I., Döbbeling U., Rusconi S. Zinc finger mutations that alter domain interactions in the glucocorticoid receptor. J. Mol. Biol. 230:1993;124-136.
4. Van Tilborg M. A. A., Bonvin A. M. J. J., Hård K., Davis A. L., Maler B., Yamamoto K. R., Kaptein R. Structure refinement of the glucocorticoid receptor-DNA binding domain from NMR data by relaxation matrix calculations. J. Mol. Biol. 247:1995;689-700.
5. Luisi B. F., Xu X. W., Otwinowski Z., Freedman L. P., Yamamoto K. R. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature. 352:1991;497-505.
6. Dahlman-Wright K., Baumann H., McEwan I. J., Almlöf T., Wright A. P. H., Gustafsson J.-Å., Härd T. Structural characterization of a minimal functional transactivation domain from the human glucocorticoid receptor. Proc. Natl. Acad. Sci. USA. 92:1995;1699-1703.
7. Chamberlain N. L., Whitacre D. C., Miesfeld R. L. Delineation of two distinct type 1 activation functions in the androgen receptor amino-terminal domain. J. Biol. Chem. 271:1996;26772-26778.
8. Kupfer S. R., Wilson E. M., French F. S. Androgen and glucocorticoid receptors interact with insulin degrading enzyme. J. Biol. Chem. 269:1994;20622-20628.
9. Kallio P. J., Poukka H., Moilanen A., Jänne O. A., Palvimo J. J. Androgen receptor-mediated transcriptional regulation in the absence of direct interaction with a specific DNA element. Mol. Endocrinol. 9:1995;1017-1028.
10. Schneikert J., Peterziel H., Defossez P.-A., Klocker H., de Launoit Y., Cato A. C. B. Androgen receptor-Ets protein interaction is a novel mechanism for steroid hormone mediated down-modulation of matrix metalloproteinase expression. J. Biol. Chem. 271:1996;23907-23913.
11. Kaspar F., Klocker H., Denninger A., Cato A. C. B. A mutant androgen receptor from patients with Reifenstein syndrome: Identification of the function of a conserved alanine residue in the D box of steroid receptors. Mol. Cell. Biol. 13:1993;7850-7858.
12. Gast A., Neuschmid-Kaspar F., Klocker H., Cato A. C. B. A single amino acid exchange abolishes dimerization of the androgen receptor and causes Reifenstein syndrome. Mol Cell. Endocrinol. 111:1995;93-98.
13. Nebl G., Cato A. C. B. NFI/X proteins: A class of NFI family of transcription factors with positive and negative regulatory domains. Cell. Mol. Biol. Res. 41:1995;85-95.
14. Iñiguez-Liuhi J. A., Lou D. Y., Yamamoto K. R. Three amino acid substitutions selectively disrupt the activation but not the repression function of the glucocorticoid receptor N terminus. J. Biol. Chem. 272:1997;4149-4156.
15. Pearce D., Yamamoto K. R. Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science. 259:1993;1161-1165.
16. Heck S., Kullmann M., Gast A., Ponta H., Rahmsdorf H. J., Herrlich P., Cato A. C. B. A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J. 13:1994;4087-4095.
17. Palvimo J. J., Kallio P. J., Ikonen T., Mehto M., Jänne O. A. Dominant negative regulation of trans-activation by the rat androgen receptor: Role of the N-terminal domain and heterodimer formation. Mol. Endocrinol. 7:1993;1399-1407.
18. Dahlman-Wright K., Wright A. P., Gustafsson J.-Å. Determinants of high-affinity DNA binding by the glucocorticoid receptor: Evaluation of receptor domains outside the DNA binding domain. Biochemistry. 31:1992;9040-9044.
19. Eriksson P., Wrange Ö. Protein-protein contacts in the glucocorticoid receptor homodimer influence its DNA binding properties. J. Biol. Chem. 265:1990;3535-3542.
20. Simental J. A., Sar M., Lane M. V., French F. S., Wilson E. M. Transcriptional activation and nuclear targeting signals of the human androgen receptor. J. Biol. Chem. 266:1991;510-518.